JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.19B |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$680M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$663M |
| 5 |
SLB Ltd
SLB
|
+$522M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$2.45B |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$1.03B |
| 3 |
McKesson
MCK
|
+$941M |
| 4 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$875M |
| 5 |
Coca-Cola
KO
|
+$711M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.24% |
| 2 | Technology | 11.01% |
| 3 | Healthcare | 9.91% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHK
1926
DELISTED
Chesapeake Energy Corporation
CHK
| $6.88M | ﹤0.01% |
5,484
-316
| -5% | -$364K |
|
|
KND
1927
DELISTED
Kindred Healthcare
KND
| $6.86M | ﹤0.01% |
670,966
+24,612
| +4% | +$273K |
|
1928
Piper Sandler
PIPR
$5.54B
| $6.83M | ﹤0.01% |
565,784
-6,828
| -1% | -$74.4K |
|
|
FPRX
1929
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $6.81M | ﹤0.01% |
129,775
+49,146
| +61% | +$2.35M |
|
1930
Dick's Sporting Goods
DKS
$18.1B
| $6.81M | ﹤0.01% |
120,008
-121,232
| -50% | -$6.67M |
|
1931
Avient
AVNT
$4.23B
| $6.8M | ﹤0.01% |
201,228
+136,221
| +210% | +$4.72M |
|
|
SIOX
1932
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $6.73M | ﹤0.01% |
60,090
-49,241
| -45% | -$5.91M |
|
1933
PUT
CNX Resources
CNX
$5.23B
| $6.72M | ﹤0.01% |
420,120
| – | – |
|
|
CUDA
1934
DELISTED
Barracuda Networks, Inc.
CUDA
| $6.68M | ﹤0.01% |
262,082
+37,467
| +17% | +$822K |
|
1935
CALL
Macy's
M
$6.27B
| $6.67M | ﹤0.01% |
+180,000
| New | +$6.52M |
|
|
PMC
1936
DELISTED
PharMerica Corporation
PMC
| $6.66M | ﹤0.01% |
237,395
+3,200
| +1% | +$82K |
|
|
ZEUS
1937
DELISTED
Olympic Steel
ZEUS
| $6.66M | ﹤0.01% |
301,350
+48,111
| +19% | +$1.15M |
|
1938
Tapestry
TPR
$25.9B
| $6.64M | ﹤0.01% |
181,710
-288,767
| -61% | -$11.4M |
|
1939
Live Nation Entertainment
LYV
$43.3B
| $6.63M | ﹤0.01% |
241,362
+97,146
| +67% | +$2.53M |
|
1940
Pegasystems
PEGA
$5.51B
| $6.62M | ﹤0.01% |
449,200
-54,314
| -11% | -$737K |
|
1941
PUT
Cognex
CGNX
$10.4B
| $6.62M | ﹤0.01% |
+250,600
| New | +$6.01M |
|
|
BLUE
1942
DELISTED
bluebird bio
BLUE
| $6.61M | ﹤0.01% |
7,534
+954
| +14% | +$691K |
|
|
MB
1943
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $6.56M | ﹤0.01% |
333,563
-297,912
| -47% | -$5.22M |
|
1944
First Trust North American Energy Infrastructure Fund
EMLP
$4.16B
| $6.55M | ﹤0.01% |
258,744
+1,655
| +0.6% | +$41.2K |
|
1945
Interface
TILE
$2.24B
| $6.54M | ﹤0.01% |
391,892
+59,664
| +18% | +$996K |
|
1946
Pediatrix Medical
MD
$2.14B
| $6.53M | ﹤0.01% |
98,619
-408
| -0.4% | -$27.9K |
|
1947
Arch Capital
ACGL
$33.5B
| $6.52M | ﹤0.01% |
246,771
-329,010
| -57% | -$8.37M |
|
|
ARI
1948
Apollo Commercial Real Estate
ARI
$886M
| $6.51M | ﹤0.01% |
397,526
+194,928
| +96% | +$3.2M |
|
1949
Jakks Pacific
JAKK
$294M
| $6.5M | ﹤0.01% |
75,245
+40,132
| +114% | +$3.6M |
|
|
GRA
1950
DELISTED
W.R. Grace & Co.
GRA
| $6.49M | ﹤0.01% |
87,978
+47,991
| +120% | +$3.62M |
|
Similar funds
JP Morgan Chase's Q3 2016 Portfolio in Review
As of Q3 2016, JP Morgan Chase held 5,175 positions worth $406B, up 1.3% from $401B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase withdrew a net $15.4B in Q3 2016, closing 607 positions and reducing 1,910 holdings. Its most notable exit was COLUMBIA PIPELINE GROUP IN COM STK (DE), an estimated $395M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Patheon N.V. worth $91.3M.
- JP Morgan Chase's largest Q3 2016 buy was Patheon N.V.: 3,082,044 shares worth $91.3M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $4B increase.
- JP Morgan Chase's biggest Q3 2016 reduction was Xtrackers MSCI EAFE Hedged Equity ETF, cutting an estimated $2.45B.
- JP Morgan Chase fully exited COLUMBIA PIPELINE GROUP IN COM STK (DE) in Q3 2016, selling an estimated $395M.
- JP Morgan Chase's ten largest holdings make up 18% of its $406B portfolio in Q3 2016.
- JP Morgan Chase opened 337 new positions and closed 607 in Q3 2016.
- JP Morgan Chase's portfolio value rose 1.3% quarter-over-quarter to $406B.
Based on JP Morgan Chase's 13F filing for Q3 2016, filed 4 Nov 2016.